1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

Document Sample
1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Powered By Docstoc
					                                                                Complying to 91/155/EC, 93/112/EC

                     Product Safety Data Sheet
                        Prednicare Tablets


1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

     Product Name                  Prednicare Tablets
     Product Code                  1 mg x 500 - XVD 481
                                   1 mg x 1000 - XVD 482
                                   5 mg x 500 - XVD 483
                                   5 mg x 1000 - XVD 484
     Supplier                      Animalcare Ltd,
                                   Common Road,
                                   Dunnington,
                                   York, YO19 5RU,
                                   Telephone No. +44 (0) 1904 487687
                                   Fax No.        +44 (0) 1904 487611
                                   E-Mail: animalcare@animalcare.co.uk.
                                   Emergency Telephone +44 (0) 1904 487687 (daytime)



2.   HAZARDS IDENTIFICATION

      This product will not pose any health problems unless damaged. If product is damaged the dust


_____________________________________________________________________________________



3.   COMPOSITION / INFORMATION ON COMPONENTS

                                  CAS No.                   FINECS No.
      Prednisolone                 50-24-8




Revision Date: January, 2005           Printing Date: 25 May, 2012                  Page 1 of 5
                                                                   Complying to 91/155/EC, 93/112/EC

                     Product Safety Data Sheet
                        Prednicare Tablets

4.    FIRST AID MEASURES
      Skin contact:          Wash with soap and water and seek medical advice.

      Eye contact:           If substance has got into eyes, immediately wash out with plenty of
                             water for at least 15 minutes.
                             Seek medical attention if irritation persists.

      Inhalation:            Remove to fresh air. Seek medical advice for discomfort.

      Ingestion:             Drink plenty of water and seek medical advice.




5.   FIRE FIGHTING MEASURES


      Extinguishing Agents:         Use water, water fog, foam or dry powder to put out a fire.



6.   ACCIDENTAL RELEASE MEASURES

     Procedures for clean up:       Sweep up product and dust and put into plastic bag for disposal.
                                    Follow UK procedures for disposal of medicinal products.



7.   HANDLING AND STORAGE

      Keep in clearly labelled airtight & lightproof containers.
      Use techniques that keep dust to a minimum.
      Avoid breathing dust and contact with skin, eyes and clothing.
      Do not consume food or smoke when handling material.
      Wash hands thoroughly after use.
     Keep in a cool and dry area.


Revision Date: January, 2005             Printing Date: 25 May, 2012                Page 2 of 5
                                                                  Complying to 91/155/EC, 93/112/EC

                     Product Safety Data Sheet
                        Prednicare Tablets



8.    EXPOSURE CONTROLS / PERSONAL PROTECTION

      Protective gloves should be used while handling this product in bulk quantities.



9.    PHYSICAL AND CHEMICAL PROPERTIES

      Form:          Solid tablet
      Colour:        White
      Odour:         Odourless
      Solubility:    In water: 1 in 1300
                     In solvents: 1 in 30 EtoH, 1 in 50 Acetone



10.   STABILITY AND REACTIVITY

      Stability:                     Stable at ambient temperatures
      Hazardous
      decomposition products:        When heated to decomposition emits acrid smoke and fumes.
      Hazardous reactions:           Oxidising agents, solvents and strong acids.



11.   TOXICOLOGICAL INFORMATION

      Oral:                  Mouse LD50: 1680mg/kg body weight
      Subcutaneous:          Rat LD50: 147mg/kg body weight
      Intravenous:           Rat LD50: 120mg/kg body weight
      Intra-peritoneal:      Rat LD50: 2000mg/kg body weight


      Short Term Effects: May cause water retention with oedema and hypertension.

Revision Date: January, 2005               Printing Date: 25 May, 2012                   Page 3 of 5
                                                                  Complying to 91/155/EC, 93/112/EC

                    Product Safety Data Sheet
                       Prednicare Tablets

      Long Term Effects: Prolonged absorption or ingestion or large doses may produce hirsutism,
                         moon face, flushing, increased bruising, acne, and a possibility of a fully
                         developed Cushing’s syndrome.



12.   ECOLOGICAL INFORMATION
      No assessment has been carried out but decomposition products have the potential to cause air
      pollution.



13.   DISPOSAL CONSIDERATIONS
      Disposal should be in accordance with local, regional or national legislation. The material should
      be incinerated in a licensed facility.



14.   TRANSPORT INFORMATION

      Land Transport:                              UN Number:             2811
      EINECS Number:        200-021-00             Tariff Number:         2937 21 00
      CUS Number:           Class 6.1              Packaging:             Packaging group III




15.   REGULATORY INFORMATION

      Classification:       T: Toxic
      Labelling:
      Symbol(s):
      R-Phrases:            R61     May cause harm to the unborn child
      S-Phrases:            S22     Do not breathe dust
                            S36/37 Wear suitable protective clothing and gloves


Revision Date: January, 2005            Printing Date: 25 May, 2012                    Page 4 of 5
                                                                 Complying to 91/155/EC, 93/112/EC

                    Product Safety Data Sheet
                       Prednicare Tablets

                            S45    In case of accident or if you feel unwell seek medical advice
                                   immediately (show label where possible).
                            S53    Avoid exposure – Obtain special instructions before use.



16.   OTHER INFORMATION

      For animal treatment only.
      We believe the statements, technical information and recommendations contained herein are
      reliable, but they are given without warranty or guarantee of any kind, express or implied, and we
      assume no responsibility for any loss, damage or expense, direct or consequential, arising out of
      their use.




Revision Date: January, 2005           Printing Date: 25 May, 2012                   Page 5 of 5

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:9
posted:5/25/2012
language:English
pages:5